Wulf-Dieter Moll

Title: Wulf-Dieter Moll: Innovator in Enzymatic Detoxification

Introduction

Wulf-Dieter Moll is a notable inventor based in Stockerau, Austria. He has made significant contributions to the field of enzymatic detoxification, particularly concerning zearalenone, a mycotoxin that poses health risks.

Latest Patents

Moll holds three patents, with his latest innovations focusing on methods for the cleavage of zearalenone. One of his patents describes a method for increasing the stability of an α/β-hydrolase, which is crucial for degrading zearalenone. This invention also includes α/β-hydrolases that have a decreased grand average of hydropathy (GRAVY) value and specific mutations. Another patent involves a polypeptide for the enzymatic detoxification of zearalenone, specifically a monooxygenase that converts the keto group in position 7 of zearalenone into an ester group. This polypeptide is characterized by its amino acid sequences, which have a high degree of sequence identity.

Career Highlights

Throughout his career, Wulf-Dieter Moll has worked with prominent companies such as Erber Aktiengesellschaft and DSM Austria GmbH. His work in these organizations has allowed him to develop and refine his innovative approaches to enzymatic detoxification.

Collaborations

Moll has collaborated with notable colleagues, including Eva Maria Binder and Gerd Schatzmayr. These partnerships have contributed to the advancement of his research and inventions.

Conclusion

Wulf-Dieter Moll's contributions to the field of enzymatic detoxification through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the safety and health sectors by addressing the challenges posed by mycotoxins.